SOSEI R & D LTD has a total of 253 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United Kingdom and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are INTRACELLULAR THERAPIES INC, TIANJIN TIANSHILI PHARMACEUTIC and SIGNAL CREATION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 30 | |
#2 | United Kingdom | 30 | |
#3 | Canada | 23 | |
#4 | Brazil | 20 | |
#5 | China | 20 | |
#6 | Israel | 20 | |
#7 | Republic of Korea | 19 | |
#8 | Norway | 19 | |
#9 | WIPO (World Intellectual Property Organization) | 19 | |
#10 | Mexico | 17 | |
#11 | South Africa | 12 | |
#12 | Australia | 10 | |
#13 | United States | 7 | |
#14 | New Zealand | 3 | |
#15 | Hong Kong | 2 | |
#16 | Argentina | 1 | |
#17 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Baxter Andrew Douglas | 81 |
#2 | Bannister Robin Mark | 59 |
#3 | Walmsley Andrea | 33 |
#4 | Brew John | 27 |
#5 | Lyne Michael Harvey | 22 |
#6 | Snape Susan | 18 |
#7 | Lasterra Elena | 15 |
#8 | Sinden Kenneth Walter | 15 |
#9 | Douglas Baxter Andrew | 11 |
#10 | Booles Clive | 10 |
Publication | Filing date | Title |
---|---|---|
GB0904044D0 | The treatment of inflammatory disorders and pain | |
GB0903548D0 | Child resistant container | |
GB0901727D0 | The treatment of ophthalmic diseases | |
GB0900356D0 | Novel cyclic compounds | |
GB0820986D0 | The treatment of inflammatory disorder and pain | |
GB0819643D0 | New therapy | |
GB0819644D0 | New therapy | |
GB0819645D0 | New therapy | |
GB0819642D0 | New therapy | |
GB0817330D0 | The treatment of inflammatory disorders and pain | |
GB0813850D0 | Salts | |
GB0803715D0 | Child resistant container | |
GB0803397D0 | The treatment of inflammatory disorders and pain | |
GB0801511D0 | The treatment of ophthalmic diseases | |
GB0725272D0 | Novel cyclic compounds | |
GB0722524D0 | The treatment of inflammatory disorders and pain | |
GB0721011D0 | New therapy | |
GB0721013D0 | New Salts | |
GB0721012D0 | New therapy | |
GB0721010D0 | New therapy |